Elevated expression of MPO has previously been demonstrated in chronic neurological disease states, such as Alzheimer's disease [50], Parkinson's disease [51], multiple sclerosis [52], and autism spectrum disorder [53]. This evidence concerns the gene MPO and early-onset autosomal dominant Alzheimer disease.